Stryker offers a diverse array of innovative medical technologies, including reconstructive, medical and surgical, and neurotechnology and spine products to help people lead more active and more satisfying lives. Stryker acquired MAKO Surgical Corporation, a pioneer in the advancement of robotic- arm assisted surgery in orthopaedics, in December of 2013. Stryker’s Mako robotic-arm assisted reconstructive surgery is transforming orthopaedics, combining Stryker’s market-leading implants with Mako’s proprietary robotic-arm technology. Over 100,000 Mako hip and knee procedures have been performed since 2006.
Key benefits include:
- CT derived, patient-specific 3-D modeling enables accurate planning of implant size.
- Real-time intra-operative adjustments allow for more correct knee kinematics and soft-tissue balance prior to resection
- Provides excellent accuracy and precision with regard to planned cup position, leg length, and offset
- Allows single stage reaming for the hip.
The Mako platform is supported by significant primary clinical research, including more than 50 peer reviewed clinical publications, over 300 scientific abstracts, and numerous ongoing clinical studies. Stryker is one of the world’s leading medical technology companies and together with our customers, we are driven to make healthcare better.